期刊文献+

二甲双胍治疗2型糖尿病临床分析 被引量:21

下载PDF
导出
摘要 目的:研究服用二甲双胍治疗2型糖尿病(T2DM)的临床疗效。方法:选取符合T2DM标准的患者75例,采用随机、平行、开放、多中心的前瞻性观察,测量治疗前后三酰甘油(TG)、糖化血红蛋白Alc(HbAlc)、空腹血糖(FPG)、餐后2h血糖(2hPG)、低密度脂蛋白(LDL-C)和高密度脂蛋白(HDL-C)。结果:T2DM患者TG、HbAlc、FPG、2hPG、LDL-C经治疗均有明显下降,HDL-C显著升高,治疗前后有显著性差异。结论:二甲双胍作为2型糖尿病患者的首选药物,能使患者血糖水平下降,并有降血脂作用,是治疗2型糖尿病的有效药物。
作者 鲜玉珍
出处 《中国医药导报》 CAS 2008年第11期75-75,96,共2页 China Medical Herald
  • 相关文献

参考文献4

  • 1[1]Nathan DM,Buse JB,Davidson MB,et al.Management of hyperglycaemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy[J].Diabetologia,2006,49:1711-1721.
  • 2[2]Stefanovi V,Anti S,Mitic-Zlatkovi M,et al.Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin[J].Diabetes Metab Res Rev,1999,15:400-404.
  • 3[3]Stumvoll M,Nurjhan N,Perriello G,et al.Metabolic effects of metformin in non-insulin-dependent diabetes mellitus[J].N Endl J Med,1995,333:550-554.
  • 4朱素君,谢锦桃,刘军,任宝江,杨重浙,江婕,蒋妮.二甲双胍:2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,27(4). 被引量:3

二级参考文献10

  • 1Hayakawa T, Nagai Y, Taniguchi M, et al. Tumor necrosis factor-beta gene NcoI polymorphism decreases insulin resistance in Japanese men. Metabolism, 2000,49: 1506-1509.
  • 2Dagogo-Jack S, Santiago JV. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med, 1997, 157:1802-1817.
  • 3Ragucci E, Zonszein J, Frishman WH. Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease. Heart Dis,2003,5:18-33.
  • 4IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med,2006,23:579-593.
  • 5Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association; European Association for the Study of Diabetes. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 2006,49: 1711-1721.
  • 6Stefanovi V, Anti S, Mitic-Zlatkovi M, et al. Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metfonnin. Diabetes Metab Res Rev, 1999,15:400-404.
  • 7Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of mefformin in non-instdin-dependent diabetes mellitus. N Engl J Med, 1995,333: 550-554.
  • 8Ratner R, Goldberg R, Haffner S, et al. Diabetes Prevention Program Research Group. Impact of intensive ligestyle and mefformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care,2005,28 : 888-894.
  • 9高妍,冯晋光,李长红,冯琦,郑家玑,高燕明,施曼珠,陈澜,惠岩.拜糖平和美迪康对2型糖尿病降糖作用的临床疗效比较[J].中华内分泌代谢杂志,1998,14(1):8-10. 被引量:18
  • 10叶山东,莫蔚林,李素梅,杨静,邢学农,周志中.二甲双胍对初发2型糖尿病患者动脉粥样硬化危险因素的影响[J].中国糖尿病杂志,1999,7(2):108-109. 被引量:1

共引文献2

同被引文献105

引证文献21

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部